Multiple Technology Appraisals (MTAs)
MTAs evaluate multiple drugs in the same indication. In MTAs, SCHARR-TAG systematically reviews, synthesises the clinical evidence, and constructs its own mathematical model providing estimates of cost-effectiveness to the NICE appraisal committee.
Off